Finding a winning formula in Sweden
In his journey to transform Meda AB from a small pharmaceutical distributor to a specialty pharmaceutical company, CEO Anders Lönner kept a steady course. Under his management, sales have increased from around €90 million to more than €1.2 billion in 10 years.
By abandoning research and focusing on mature niche products and final-phase projects, Meda quickly found a successful growth strategy. Meda operates in 50 countries and sells its products in 120 countries.